{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T12:04:18Z","timestamp":1774008258793,"version":"3.50.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T00:00:00Z","timestamp":1557792000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T00:00:00Z","timestamp":1557792000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Internist"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1007\/s00108-019-0616-5","type":"journal-article","created":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T14:23:11Z","timestamp":1557843791000},"page":"669-677","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Pneumocystis-jirovecii-Pneumonie \u2013 eine opportunistische Infektion im Wandel","Pneumocystis jirovecii pneumonia\u2014an opportunistic infection undergoing change"],"prefix":"10.1007","volume":"60","author":[{"given":"F.","family":"Hitzenbichler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Mohr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Salzberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,5,14]]},"reference":[{"issue":"Suppl 2","key":"616_CR1","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.cmi.2017.12.025","volume":"24","author":"JW Baddley","year":"2018","unstructured":"Baddley JW, Cantini F, Goletti D, G\u00f3mez-Reino JJ, Mylonakis E, San-Juan R, Fern\u00e1ndez-Ruiz M, Torre-Cisneros J (2018) ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies. An infectious diseases perspective (Soluble immune effector molecules I: anti-tumor necrosis factor-\u03b1 agents). Clin Microbiol Infect 24(Suppl 2):10\u201320. \n                    https:\/\/doi.org\/10.1016\/j.cmi.2017.12.025","journal-title":"Clin Microbiol Infect"},{"key":"616_CR2","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ijid.2016.03.018","volume":"46","author":"A-L Bienvenu","year":"2016","unstructured":"Bienvenu A\u2011L, Traore K, Plekhanova I, Bouchrik M, Bossard C, Picot S (2016) Pneumocystis pneumonia suspected cases in 604 non-HIV and HIV patients. Int J Infect Dis 46:11\u201317. \n                    https:\/\/doi.org\/10.1016\/j.ijid.2016.03.018","journal-title":"Int J Infect Dis"},{"issue":"4","key":"616_CR3","doi-asserted-by":"publisher","first-page":"792","DOI":"10.3899\/jrheum.090843","volume":"37","author":"D Cettomai","year":"2010","unstructured":"Cettomai D, Gelber AC, Christopher-Stine L (2010) A survey of rheumatologists\u2019 practice for prescribing pneumocystis prophylaxis. J\u00a0Rheumatol 37(4):792\u2013799. \n                    https:\/\/doi.org\/10.3899\/jrheum.090843","journal-title":"J Rheumatol"},{"issue":"4","key":"616_CR4","doi-asserted-by":"publisher","first-page":"ofx193","DOI":"10.1093\/ofid\/ofx193","volume":"4","author":"L Doyle","year":"2017","unstructured":"Doyle L, Vogel S, Procop GW (2017) Pneumocystis PCR. It is time to make PCR the test of choice. Open Forum Infect Dis 4(4):ofx193. \n                    https:\/\/doi.org\/10.1093\/ofid\/ofx193","journal-title":"Open Forum Infect Dis"},{"issue":"9182","key":"616_CR5","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/S0140-6736(98)10328-8","volume":"354","author":"MW Dunne","year":"1999","unstructured":"Dunne MW, Bozzette S, McCutchan JA, Dub\u00e9 MP, Sattler FR, Forthal D, Kemper CA, Havlir D (1999) Efficacy of azithromycin in prevention of Pneumocystis carinii pneumonia. A randomised trial. California Collaborative Treatment Group. Lancet 354(9182):891\u2013895","journal-title":"Lancet"},{"issue":"6182","key":"616_CR6","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/334519a0","volume":"334","author":"JC Edman","year":"1988","unstructured":"Edman JC, Kovacs JA, Masur H, Santi DV, Elwood HJ, Sogin ML (1988) Ribosomal RNA sequence shows Pneumocystis carinii to be a\u00a0member of the fungi. Nature 334(6182):519\u2013522. \n                    https:\/\/doi.org\/10.1038\/334519a0","journal-title":"Nature"},{"issue":"7","key":"616_CR7","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1007\/s10096-014-2054-6","volume":"33","author":"F Esteves","year":"2014","unstructured":"Esteves F, Lee C\u2011H, de Sousa B, Badura R, Seringa M, Fernandes C, Gaspar JF, Antunes F, Matos O (2014) (1-3)-beta-D-glucan in association with lactate dehydrogenase as biomarkers of Pneumocystis pneumonia (PcP) in HIV-infected patients. Eur J Clin Microbiol Infect Dis 33(7):1173\u20131180. \n                    https:\/\/doi.org\/10.1007\/s10096-014-2054-6","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"616_CR8","doi-asserted-by":"publisher","first-page":"CD006150","DOI":"10.1002\/14651858.CD006150.pub2","volume":"4","author":"H Ewald","year":"2015","unstructured":"Ewald H, Raatz H, Boscacci R, Furrer H, Bucher HC, Briel M (2015) Adjunctive corticosteroids for Pneumocystis jiroveci pneumonia in patients with HIV infection. Cochrane Database Syst Rev 4:CD6150. \n                    https:\/\/doi.org\/10.1002\/14651858.CD006150.pub2","journal-title":"Cochrane Database Syst Rev"},{"issue":"8631","key":"616_CR9","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/S0140-6736(89)91241-5","volume":"333","author":"G Faetkenheuer","year":"1989","unstructured":"Faetkenheuer G, Salzberger B, Allolio B, Pothoff G, Schrappe-Baecher M (1989) Exercise Oximetry for early diagnosis of Pneumocystis Carinii pneumonia. Lancet 333(8631):222. \n                    https:\/\/doi.org\/10.1016\/S0140-6736(89)91241-5","journal-title":"Lancet"},{"issue":"6","key":"616_CR10","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1128\/JCM.03174-15","volume":"54","author":"T Fauchier","year":"2016","unstructured":"Fauchier T, Hasseine L, Gari-Toussaint M, Casanova V, Marty PM, Pomares C (2016) Detection of Pneumocystis jirovecii by quantitative PCR to differentiate colonization and pneumonia in Immunocompromised HIV-positive and HIV-negative patients. J\u00a0Clin Microbiol 54(6):1487\u20131495. \n                    https:\/\/doi.org\/10.1128\/JCM.03174-15","journal-title":"J Clin Microbiol"},{"issue":"2","key":"616_CR11","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1378\/chest.128.2.573","volume":"128","author":"E Festic","year":"2005","unstructured":"Festic E, Gajic O, Limper AH, Aksamit TR (2005) Acute respiratory failure due to pneumocystis pneumonia in patients without human immunodeficiency virus infection. Outcome and associated features. Chest 128(2):573\u2013579. \n                    https:\/\/doi.org\/10.1378\/chest.128.2.573","journal-title":"Chest"},{"issue":"2","key":"616_CR12","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/S0022-3476(78)80028-6","volume":"92","author":"WT Hughes","year":"1978","unstructured":"Hughes WT, Feldman S, Chaudhary SC, Ossi MJ, Cox F, Sanyal SK (1978) Comparison of pentamidine isethionate and trimethoprim-sulfamethoxazole in the treatment of Pneumocystis carinii pneumonia. J\u00a0Pediatr 92(2):285\u2013291","journal-title":"J Pediatr"},{"key":"616_CR13","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.ijid.2018.12.001","volume":"79","author":"N Inoue","year":"2018","unstructured":"Inoue N, Fushimi K (2018) Adjunctive Corticosteroids decreased the risk of mortality of non-HIV Pneumocystis Pneumonia. Int J Infect Dis 79:109\u2013115. \n                    https:\/\/doi.org\/10.1016\/j.ijid.2018.12.001","journal-title":"Int J Infect Dis"},{"issue":"1","key":"616_CR14","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/j.1469-0691.2011.03760.x","volume":"19","author":"DE Karageorgopoulos","year":"2013","unstructured":"Karageorgopoulos DE, Qu J\u2011M, Korbila IP, Zhu Y\u2011G, Vasileiou VA, Falagas ME (2013) Accuracy of \u03b2\u2011D-glucan for the diagnosis of Pneumocystis jirovecii pneumonia. A meta-analysis. Clin Microbiol Infect 19(1):39\u201349. \n                    https:\/\/doi.org\/10.1111\/j.1469-0691.2011.03760.x","journal-title":"Clin Microbiol Infect"},{"issue":"Suppl 4","key":"616_CR15","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1111\/ajt.12119","volume":"13","author":"SI Martin","year":"2013","unstructured":"Martin SI, Fishman JA (2013) Pneumocystis pneumonia in solid organ transplantation. Am J Transplant 13(Suppl 4):272\u2013279. \n                    https:\/\/doi.org\/10.1111\/ajt.12119","journal-title":"Am J Transplant"},{"issue":"1","key":"616_CR16","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1186\/s12879-018-3303-6","volume":"18","author":"F Mendelson","year":"2018","unstructured":"Mendelson F, Griesel R, Tiffin N, Rangaka M, Boulle A, Mendelson M, Maartens G (2018) C\u2011reactive protein and procalcitonin to discriminate between tuberculosis, Pneumocystis jirovecii pneumonia, and bacterial pneumonia in HIV-infected inpatients meeting WHO criteria for seriously ill. A prospective cohort study. Bmc Infect Dis 18(1):399. \n                    https:\/\/doi.org\/10.1186\/s12879-018-3303-6","journal-title":"Bmc Infect Dis"},{"issue":"Suppl 2","key":"616_CR17","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.cmi.2018.02.003","volume":"24","author":"M Mikulska","year":"2018","unstructured":"Mikulska M, Lanini S, Gudiol C, Drgona L, Ippolito G, Fern\u00e1ndez-Ruiz M, Salzberger B (2018) ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies. An infectious diseases perspective (Agents targeting lymphoid cells surface antigens I: CD19, CD20 and CD52). Clin Microbiol Infect 24(Suppl 2):71\u201382. \n                    https:\/\/doi.org\/10.1016\/j.cmi.2018.02.003","journal-title":"Clin Microbiol Infect"},{"issue":"5","key":"616_CR18","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1186\/ar2826","volume":"11","author":"F Moosig","year":"2009","unstructured":"Moosig F, Holle JU, Gross WL (2009) Value of anti-infective chemoprophylaxis in primary systemic vasculitis. What is the evidence? Arthritis Res Ther 11(5):253. \n                    https:\/\/doi.org\/10.1186\/ar2826","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"616_CR19","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s00277-013-1698-0","volume":"92","author":"S Neumann","year":"2013","unstructured":"Neumann S, Krause SW, Maschmeyer G, Schiel X, von Lilienfeld-Toal M (2013) Primary prophylaxis of bacterial infections and Pneumocystis jirovecii pneumonia in patients with hematological malignancies and solid tumors. Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Ann Hematol 92(4):433\u2013442. \n                    https:\/\/doi.org\/10.1007\/s00277-013-1698-0","journal-title":"Ann Hematol"},{"issue":"3","key":"616_CR20","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1086\/649868","volume":"50","author":"CA Ponce","year":"2010","unstructured":"Ponce CA, Gallo M, Bustamante R, Vargas SL (2010) Pneumocystis colonization is highly prevalent in the autopsied lungs of the general population. Clin Infect Dis 50(3):347\u2013353. \n                    https:\/\/doi.org\/10.1086\/649868","journal-title":"Clin Infect Dis"},{"issue":"1","key":"616_CR21","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1159\/000487713","volume":"96","author":"HJF Salzer","year":"2018","unstructured":"Salzer HJF, Sch\u00e4fer G, Hoenigl M, G\u00fcnther G, Hoffmann C, Kalsdorf B, Alanio A, Lange C (2018) Clinical, diagnostic, and treatment disparities between HIV-infected and non-HIV-infected Immunocompromised patients with Pneumocystis jirovecii pneumonia. Respiration 96(1):52\u201365. \n                    https:\/\/doi.org\/10.1159\/000487713","journal-title":"Respiration"},{"issue":"3","key":"616_CR22","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1128\/JCM.02876-15","volume":"54","author":"M Sasso","year":"2016","unstructured":"Sasso M, Chastang-Dumas E, Bastide S, Alonso S, Lechiche C, Bourgeois N, Lachaud L (2016) Performances of four real-time PCR assays for diagnosis of Pneumocystis jirovecii pneumonia. J\u00a0Clin Microbiol 54(3):625\u2013630. \n                    https:\/\/doi.org\/10.1128\/JCM.02876-15","journal-title":"J Clin Microbiol"},{"issue":"1","key":"616_CR23","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1186\/s13054-018-2221-8","volume":"22","author":"JJ Schmidt","year":"2018","unstructured":"Schmidt JJ, Lueck C, Ziesing S, Stoll M, Haller H, Gottlieb J, Eder M, Welte T, Hoeper MM, Scherag A, David S (2018) Clinical course, treatment and outcome of Pneumocystis pneumonia in immunocompromised adults. A retrospective analysis over 17 years. Crit Care 22(1):307. \n                    https:\/\/doi.org\/10.1186\/s13054-018-2221-8","journal-title":"Crit Care"},{"key":"616_CR24","doi-asserted-by":"publisher","DOI":"10.1093\/femsyr\/fov046","author":"JH Skalski","year":"2015","unstructured":"Skalski JH, Kottom TJ, Limper AH (2015) Pathobiology of Pneumocystis pneumonia. Life cycle, cell wall and cell signal transduction. Fems Yeast Res 15(6). \n                    https:\/\/doi.org\/10.1093\/femsyr\/fov046","journal-title":"Fems Yeast Res"},{"issue":"4","key":"616_CR25","doi-asserted-by":"publisher","first-page":"E111","DOI":"10.3314\/mmj.16-00019","volume":"57","author":"Y Song","year":"2016","unstructured":"Song Y, Ren Y, Wang X, Li R (2016) Recent advances in the diagnosis of Pneumocystis pneumonia. Med Mycol\u00a0J 57(4):E111\u2013E116. \n                    https:\/\/doi.org\/10.3314\/mmj.16-00019","journal-title":"Med Mycol J"},{"key":"616_CR26","doi-asserted-by":"publisher","first-page":"CD005590","DOI":"10.1002\/14651858.CD005590.pub3","volume":"10","author":"A Stern","year":"2014","unstructured":"Stern A, Green H, Paul M, Vidal L, Leibovici L (2014) Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients. Cochrane Database Syst Rev 10:CD5590. \n                    https:\/\/doi.org\/10.1002\/14651858.CD005590.pub3","journal-title":"Cochrane Database Syst Rev"},{"issue":"9","key":"616_CR27","doi-asserted-by":"publisher","first-page":"891","DOI":"10.3201\/eid0809.020096","volume":"8","author":"JR Stringer","year":"2002","unstructured":"Stringer JR, Beard CB, Miller RF, Wakefield AE (2002) A new name (Pneumocystis jiroveci) for Pneumocystis from humans. Emerging Infect Dis 8(9):891\u2013896. \n                    https:\/\/doi.org\/10.3201\/eid0809.020096","journal-title":"Emerging Infect Dis"},{"issue":"4","key":"616_CR28","doi-asserted-by":"publisher","first-page":"273","DOI":"10.2169\/internalmedicine.49.2871","volume":"49","author":"S Tasaka","year":"2010","unstructured":"Tasaka S, Tokuda H, Sakai F, Fujii T, Tateda K, Johkoh T, Ohmagari N, Ohta H, Araoka H, Kikuchi Y, Yasui M, Inuzuka K, Goto H (2010) Comparison of clinical and radiological features of pneumocystis pneumonia between malignancy cases and acquired immunodeficiency syndrome cases. A multicenter study. Intern Med 49(4):273\u2013281","journal-title":"Intern Med"},{"issue":"Suppl 2","key":"616_CR29","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s15010-013-0504-1","volume":"41","author":"J Thoden","year":"2013","unstructured":"Thoden J, Potthoff A, Bogner JR et al (2013) Therapy and prophylaxis of opportunistic infections in HIV-infected patients. A guideline by the German and Austrian AIDS societies (DAIG\/\u00d6AG) (AWMF 055\/066). Infection 41(Suppl 2):91\u2013115. \n                    https:\/\/doi.org\/10.1007\/s15010-013-0504-1","journal-title":"Infection"},{"issue":"1","key":"616_CR30","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13075-016-1206-8","volume":"19","author":"M Utsunomiya","year":"2017","unstructured":"Utsunomiya M, Dobashi H, Odani T, Saito K, Yokogawa N, Nagasaka K, Takenaka K, Soejima M, Sugihara T, Hagiyama H, Hirata S, Matsui K, Nonomura Y, Kondo M, Suzuki F, Tomita M, Kihara M, Yokoyama W, Hirano F, Yamazaki H, Sakai R, Nanki T, Koike R, Kohsaka H, Miyasaka N, Harigai M (2017) Optimal regimens of sulfamethoxazole-trimethoprim for chemoprophylaxis of Pneumocystis pneumonia in patients with systemic rheumatic diseases. Results from a\u00a0non-blinded, randomized controlled trial. Arthritis Res Ther 19(1):7. \n                    https:\/\/doi.org\/10.1186\/s13075-016-1206-8","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"616_CR31","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1093\/cid\/cis870","volume":"56","author":"SL Vargas","year":"2013","unstructured":"Vargas SL, Ponce CA, Gallo M, P\u00e9rez F, Astorga J\u2011F, Bustamante R, Chab\u00e9 M, Durand-Joly I, Iturra P, Miller RF, Aliouat EM, Dei-Cas E (2013) Near-universal prevalence of Pneumocystis and associated increase in mucus in the lungs of infants with sudden unexpected death. Clin Infect Dis 56(2):171\u2013179. \n                    https:\/\/doi.org\/10.1093\/cid\/cis870","journal-title":"Clin Infect Dis"},{"issue":"3","key":"616_CR32","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/j.chest.2018.04.026","volume":"154","author":"PM Wieruszewski","year":"2018","unstructured":"Wieruszewski PM, Barreto JN, Frazee E, Daniels CE, Tosh PK, Dierkhising RA, Mara KC, Limper AH (2018) Early Corticosteroids for Pneumocystis pneumonia in adults without HIV are not associated with better outcome. Chest 154(3):636\u2013644. \n                    https:\/\/doi.org\/10.1016\/j.chest.2018.04.026","journal-title":"Chest"},{"issue":"6","key":"616_CR33","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s11926-017-0664-6","volume":"19","author":"RM Wolfe","year":"2017","unstructured":"Wolfe RM, Peacock JE (2017) Pneumocystis pneumonia and the Rheumatologist. Which patients are at risk and how Can PCP be prevented? Curr Rheumatol Rep 19(6):35. \n                    https:\/\/doi.org\/10.1007\/s11926-017-0664-6","journal-title":"Curr Rheumatol Rep"},{"issue":"1","key":"616_CR34","doi-asserted-by":"publisher","first-page":"5","DOI":"10.4065\/71.1.5","volume":"71","author":"SH Yale","year":"1996","unstructured":"Yale SH, Limper AH (1996) Pneumocystis carinii pneumonia in patients without acquired Immunodeficiency syndrome. Associated illnesses and prior Corticosteroid therapy. Mayo Clin Proc 71(1):5\u201313. \n                    https:\/\/doi.org\/10.4065\/71.1.5","journal-title":"Mayo Clin Proc"},{"key":"616_CR35","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.rmcr.2018.12.003","volume":"26","author":"D-H Yang","year":"2019","unstructured":"Yang D\u2011H, Xu Y, Hong L, Song Z\u2011Y, Ge W\u2011H (2019) Efficacy of caspofungin combined with clindamycin for Pneumocystis jirovecii pneumonia in a\u00a0systemic lupus erythematosus patient. A case report and literature review. Respir Med Case Rep 26:108\u2013111. \n                    https:\/\/doi.org\/10.1016\/j.rmcr.2018.12.003","journal-title":"Respir Med Case Rep"},{"issue":"5","key":"616_CR36","doi-asserted-by":"publisher","first-page":"e5575","DOI":"10.1371\/journal.pone.0005575","volume":"4","author":"A Zolopa","year":"2009","unstructured":"Zolopa A, Andersen J, Powderly W, Sanchez A, Sanne I, Suckow C, Hogg E, Komarow L (2009) Early antiretroviral therapy reduces AIDS progression\/death in individuals with acute opportunistic infections. A multicenter randomized strategy trial. PLoS ONE 4(5):e5575. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0005575","journal-title":"PLoS ONE"}],"container-title":["Der Internist"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-019-0616-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00108-019-0616-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-019-0616-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T23:17:16Z","timestamp":1589325436000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00108-019-0616-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,14]]},"references-count":36,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["616"],"URL":"https:\/\/doi.org\/10.1007\/s00108-019-0616-5","relation":{},"ISSN":["0020-9554","1432-1289"],"issn-type":[{"value":"0020-9554","type":"print"},{"value":"1432-1289","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,14]]},"assertion":[{"value":"14 May 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"F.\u00a0Hitzenbichler, A.\u00a0Mohr und B.\u00a0Salzberger geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien. F\u00fcr Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts, \u00fcber die Patienten zu identifizieren sind, liegt von ihnen und\/oder ihren gesetzlichen Vertretern eine schriftliche Einwilligung vor.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}